Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| WESTELL TECH | WSTL | 7.69% |
| ALLIANCE FIB | AFOP | 5.57% |
| STEIN MART I | SMRT | 3.75% |
| DAWSON GEOPH | DWSN | 3.52% |
| MARRIOTT VAC | VAC | 3.41% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We maintain our Neutral rating on Health Management Associates ( HMA - Analyst Report ) , a leading operator of general acute care hospitals. Second-quarter fiscal 2011 earnings of 20 cents per share edged past the Zacks Consensus Estimate by a penny.
Health Management runs hospitals in select non-urban markets mostly in south eastern U.S. The company continues to emphasize its three long-standing initiatives, namely Emergency Room operations, physician recruitment and market development, which have facilitated admissions.
We are slightly relieved that bad debt may not be an area of looming concern. Overall, total uncompensated care (the sum of uninsured discounts, charity/indigent write-offs, and bad debt expense as a percentage of adjusted revenue) was on the higher side in the second quarter. The lingering level of uninsured admissions also remains a cause of concern.
Delayed care continues to raise acuity in a weak economy. In this regard, Health Management’s specialty recruitment and its market/service development are expected to drive acuity over the medium term as group hospitals become more adept at handling higher acuity patients. Also, Health Management’s deployment of modern surgical systems in its hospitals should continue to grow its surgical market share.
On the negative side, we are concerned about soft hospital industry volume trends and the company’s ability to quickly absorb hospitals. Sizeable debt remains on the balance sheet. The company’s contracts with commercial managed care organizations partially mitigate its exposure to government programs, Medicare/Medicaid.
Health Management has lifted its earnings guidance for fiscal 2011. The company now expects earnings between 76 cents and 80 cents a share versus its earlier forecast of 74 cents and 78 cents. Moreover, it expects same hospital admissions to be flat to down 2% (versus a rise of 1% to a fall of 1% earlier) for 2011.
The company has indicated its continued willingness to deploy free cash flow for acquisitions. It is an active acquirer of underperforming hospitals with a turnaround potential in high-growth markets. Health Management’s competitors, in niche markets, include Community Health Systems ( CYH - Snapshot Report ) and Lifepoint Hospitals ( LPNT - Snapshot Report ) .
Read the full Analyst Report on HMA
Read the full Snapshot Report on CYH
Read the full Snapshot Report on LPNT